Search research articles
Contact Us
Filters
Showing results (171-180 of 211) with videos related to
Page
of 22
Sort By:
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology
|
April 25, 2013
Antitumor effects of Origanum acutidens extracts on human breast cancer
E Tuncer, S Unver-Saraydin, B Tepe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1984
Bone marrow infiltration patterns and their prognostic significance in chronic lymphocytic leukemia: correlations with clinical, immunologic, phenotypic, and cytogenetic data
T Han, M Barcos, L Emrich, et al.
Journal of the National Cancer Institute
|
May 4, 1988
Randomized study of the duration of treatment with interferon alfa-2B in patients with hairy cell leukemia
H M Golomb, M J Ratain, A Fefer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1985
Phase II study of recombinant alpha-2 interferon in resistant multiple myeloma
J J Costanzi, M R Cooper, J H Scarffe, et al.
Clinical and Laboratory Haematology
|
August 11, 2006
Expression of the vascular endothelial growth factor receptors 1 and 2 in acute myeloid leukemia: incidence and feasibility of immunohistochemical staining
M A Kharfan-Dabaja, S A Patel, A O Osunkoya, et al.
Leukemia Research
|
January 1, 1986
The reproducibility of acute lymphoblastic leukemia phenotype determinations: evaluation of monoclonal antibody and conventional hematopoietic markers
R E Sobol, R Mick, T W LeBien, et al.
Blood
|
July 1, 1984
Benign monoclonal B cell lymphocytosis--a benign variant of CLL: clinical, immunologic, phenotypic, and cytogenetic studies in 20 patients
T Han, H Ozer, M Gavigan, et al.
International Urology and Nephrology
|
January 20, 2023
Could immune cells be associated with nephropathy in Fabry disease patients?
K Turkmen, M A Karaselek, S C Celik, et al.
Seminars in Oncology
|
June 1, 1987
Sequential evaluation of alpha-2b-interferon treatment in 128 patients with hairy cell leukemia
H M Golomb, A Fefer, D W Golde, et al.
Seminars in Oncology
|
June 1, 1987
Alfa-2b interferon in the treatment of Hodgkin's disease and non-Hodgkin's lymphoma
R D Leavitt, V Ratanatharathorn, H Ozer, et al.
Page
of 22
Search research articles
Search
Showing results (171-180 of 211) with videos related to
Sort By:
Page
of 22
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology
|
April 25, 2013
Antitumor effects of Origanum acutidens extracts on human breast cancer
E Tuncer, S Unver-Saraydin, B Tepe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1984
Bone marrow infiltration patterns and their prognostic significance in chronic lymphocytic leukemia: correlations with clinical, immunologic, phenotypic, and cytogenetic data
T Han, M Barcos, L Emrich, et al.
Journal of the National Cancer Institute
|
May 4, 1988
Randomized study of the duration of treatment with interferon alfa-2B in patients with hairy cell leukemia
H M Golomb, M J Ratain, A Fefer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1985
Phase II study of recombinant alpha-2 interferon in resistant multiple myeloma
J J Costanzi, M R Cooper, J H Scarffe, et al.
Clinical and Laboratory Haematology
|
August 11, 2006
Expression of the vascular endothelial growth factor receptors 1 and 2 in acute myeloid leukemia: incidence and feasibility of immunohistochemical staining
M A Kharfan-Dabaja, S A Patel, A O Osunkoya, et al.
Leukemia Research
|
January 1, 1986
The reproducibility of acute lymphoblastic leukemia phenotype determinations: evaluation of monoclonal antibody and conventional hematopoietic markers
R E Sobol, R Mick, T W LeBien, et al.
Blood
|
July 1, 1984
Benign monoclonal B cell lymphocytosis--a benign variant of CLL: clinical, immunologic, phenotypic, and cytogenetic studies in 20 patients
T Han, H Ozer, M Gavigan, et al.
International Urology and Nephrology
|
January 20, 2023
Could immune cells be associated with nephropathy in Fabry disease patients?
K Turkmen, M A Karaselek, S C Celik, et al.
Seminars in Oncology
|
June 1, 1987
Sequential evaluation of alpha-2b-interferon treatment in 128 patients with hairy cell leukemia
H M Golomb, A Fefer, D W Golde, et al.
Seminars in Oncology
|
June 1, 1987
Alfa-2b interferon in the treatment of Hodgkin's disease and non-Hodgkin's lymphoma
R D Leavitt, V Ratanatharathorn, H Ozer, et al.
Page
of 22